Application of Naoxintong combined with warfarin in anticoagulant therapy in elderly patients with coronary heart disease and atrial fibrillation

Minerva Surg. 2024 Jun;79(3):366-367. doi: 10.23736/S2724-5691.23.10170-5. Epub 2023 Dec 21.

Authors

Xiao Luo¹, Ling Chen¹, Juxiang Li², Jingsong Xu², Ran Liao³

Affiliations

¹ Department of Cardiovascular Medicine, Jiujiang First People's Hospital, Jiujiang, China.
² Department of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
³ Department of Cardiovascular Medicine, Jiujiang First People's Hospital, Jiujiang, China - liaoran202306@163.com.

PMID: 38127436
DOI: 10.23736/S2724-5691.23.10170-5

No abstract available

Publication types

Letter

MeSH terms

Aged
Aged, 80 and over
Anticoagulants* / therapeutic use
Atrial Fibrillation* / drug therapy
Coronary Disease* / drug therapy
Drug Therapy, Combination
Drugs, Chinese Herbal* / therapeutic use
Female
Humans
Male
Treatment Outcome
Warfarin* / therapeutic use

Substances

Anticoagulants
Warfarin
Drugs, Chinese Herbal